Méribel Pharma Solutions
keyboard_backspaceBack to Home
Contact
Z.a. la Gandonne, Rue du Rémoulaire
13300 Salon-de-Provence
France
Directrice Développement Commercial
About us
Meribel Pharma Solutions is a mid-sized CDMO headquartered in the United Kingdom, with 13 manufacturing and pharmaceutical development sites across France, Spain, and Sweden. The company is backed by BlueWolf Capital Partners LLC (“Blue Wolf”), a private equity firm specializing in the industrial and healthcare sectors. With cutting-edge expertise in sterile multi-dose, freeze-drying, sachets, and stick packs, as well as development services, Meribel Pharma Solutions supports its customers from the concept phase through to commercialization. It also offers manufacturing services for oral solid dosage forms (OSD) and semi-solid dosage forms.
Business offer
From an ever-expanding pool of skills and expertise, we ensure a seamless journey from concept to commercialisation, leveraging a particular specialisation and deep knowledge in Lyophilisation:
• Sterile lyophilisation
• Non-sterile lyophilisation
• Prefilled syringe non-injectable
• Bulk API lyophilisation
• Biologics and small molecule
• Freeze-drying and encapsulation of living bacteria
• A dedicated centre of excellence equipped with 15 freeze dryers, including three dedicated to sterile freeze-dried products
Activities
- Service
- Other
- CMC
- Master Cell Bank
- Production
- Bioproduction
- Fill & Finish
- Aseptic filling
- Lyophilization
- CMC
- GMP compliance
- Master Banks (cell and viral as needed)
- manufacturing
- Characterization and testing
- storage
- shipment
- Cell Culture / Fermentation
- Ability to work in BSL2 conditions
- Formulation
- Formulation
- Adjuvants
- Stabilization
- Excipients
- Lyophilization
- Shipment Monitoring
- Fill & finish
- Lyophilization
